Cass IA - Search Results

1

Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary.

Moore KN, Moxley KM, Fader AN, Axtell AE, Rocconi RP, Abaid LN, Cass IA, Rose PG, Leath CA 3rd, Rutledge T, Blankenship D, Gold MA. Moore KN, et al. Among authors: cass ia. Gynecol Oncol. 2007 Dec;107(3):398-403. doi: 10.1016/j.ygyno.2007.09.027. Epub 2007 Nov 7. Gynecol Oncol. 2007. PMID: 17997146

2

Effect of combination chemotherapy with cisplatin and cyclophosphamide on human immunodeficiency virus type-1 surrogate markers in a patient with advanced epithelial ovarian cancer.

Fishman DA, Viscarello RR, Cass I, Schwartz PE. Fishman DA, et al. Gynecol Oncol. 1995 Apr;57(1):105-8. doi: 10.1006/gyno.1995.1105. Gynecol Oncol. 1995. PMID: 7705691 Free article.

3

Combination chemotherapy with etoposide, cisplatin, and doxorubicin in mixed müllerian tumors of the adnexa.

Cass I, Resnik E, Chambers JT, Chambers SK, Carcangiu ML, Kohorn EI, Schwartz PE. Cass I, et al. Gynecol Oncol. 1996 Jun;61(3):309-14. doi: 10.1006/gyno.1996.0148. Gynecol Oncol. 1996. PMID: 8641607 Free article.

4

The prognostic significance of thrombocytosis in epithelial ovarian carcinoma.

Li AJ, Madden AC, Cass I, Leuchter RS, Lagasse LD, Karlan BY. Li AJ, et al. Gynecol Oncol. 2004 Jan;92(1):211-4. doi: 10.1016/j.ygyno.2003.09.002. Gynecol Oncol. 2004. PMID: 14751160

5

The prognostic significance of thrombocytosis in uterine papillary serous carcinomas.

Lerner DL, Walsh CS, Cass I, Karlan BY, Li AJ. Lerner DL, et al. Gynecol Oncol. 2007 Jan;104(1):91-4. doi: 10.1016/j.ygyno.2006.07.020. Epub 2006 Aug 24. Gynecol Oncol. 2007. PMID: 16934317

6

Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome.

Karam AK, Santillan A, Bristow RE, Giuntoli R 2nd, Gardner GJ, Cass I, Karlan BY, Li AJ. Karam AK, et al. Gynecol Oncol. 2007 Feb;104(2):377-80. doi: 10.1016/j.ygyno.2006.08.037. Epub 2006 Oct 2. Gynecol Oncol. 2007. PMID: 17014899

7

Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.

Santillan A, Karam AK, Li AJ, Giuntoli R 2nd, Gardner GJ, Cass I, Karlan BY, Bristow RE. Santillan A, et al. Gynecol Oncol. 2007 Mar;104(3):686-90. doi: 10.1016/j.ygyno.2006.10.020. Epub 2006 Dec 1. Gynecol Oncol. 2007. PMID: 17141302

8

Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer.

Axtell AE, Lee MH, Bristow RE, Dowdy SC, Cliby WA, Raman S, Weaver JP, Gabbay M, Ngo M, Lentz S, Cass I, Li AJ, Karlan BY, Holschneider CH. Axtell AE, et al. J Clin Oncol. 2007 Feb 1;25(4):384-9. doi: 10.1200/JCO.2006.07.7800. J Clin Oncol. 2007. PMID: 17264334

9

Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube?

Cass I, Walts A, Karlan BY. Cass I, et al. Gynecol Oncol. 2010 Apr;117(1):27-31. doi: 10.1016/j.ygyno.2009.12.023. Epub 2010 Jan 27. Gynecol Oncol. 2010. PMID: 20110118

10

Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation.

Vicus D, Finch A, Rosen B, Fan I, Bradley L, Cass I, Sun P, Karlan B, McLaughlin J, Narod SA; Hereditary Ovarian Cancer Clinical Study Group. Vicus D, et al. Gynecol Oncol. 2010 Aug 1;118(2):155-9. doi: 10.1016/j.ygyno.2010.03.009. Epub 2010 May 10. Gynecol Oncol. 2010. PMID: 20452659

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters